Literature DB >> 22223067

Percutaneous nephrolithotomy monotherapy for staghorn: paradigm shift for 'staghorn morphometry' based clinical classification.

Shashikant Mishra1, Ravindra B Sabnis, Mahesh R Desai.   

Abstract

PURPOSE OF REVIEW: The term staghorn is plagued by an unclear morphology There is a need for clinical definition of staghorn that could classify patients in either of the two ends of the treatment spectrum for percutaneous nephrolithotomy (PCNL) monotherapy. RECENT
FINDINGS: Staghorn morphometry was identified as a prognostic tool to predict tract(s) and stage(s) for PCNL monotherapy for staghorn. Staghorn morphometry requires a three-dimensional computed tomography urography assessment by volume rendering software. As per the detailed stone morphometric analysis, a clinically important definition of staghorn calculi based on the high odds probability of multiple tract(s) and stage(s) is proposed. Type 1 staghorn has a total stone volume of less than 5000 mm with less than 5% unfavorable calyx stone percentile volume, whereas type 3 staghorn has a total stone volume of more than 20,000 mm with greater than 10% unfavorable calyx stone percentile volume. Type 2 staghorn is in-between type 1 and 2. Based on the prediction model for achieving clearance by PCNL monotherapy, type 1 staghorn would require single tract and stage, type 2 single tract-single/multiple stages or multiple tract-single stage and type 3 multiple tract and stage.
SUMMARY: Staghorn morphometry based clinical classification of staghorn is an exciting concept for PCNL monotherapy. Further prospective studies are required to validate the staghorn morphometry based clinical variate of staghorns. The prospective studies should take into account clinical presentations, operative complications, tract and stage required, postoperative complications, hospital stay, operative cost and stone-free status.

Entities:  

Mesh:

Year:  2012        PMID: 22223067     DOI: 10.1097/MOU.0b013e32834fc306

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  8 in total

1.  The management of large staghorn renal stones by percutaneous versus laparoscopic versus open nephrolithotomy: a comparative analysis of clinical efficacy and functional outcome.

Authors:  Alireza Aminsharifi; Dariush Irani; Mansour Masoumi; Bahman Goshtasbi; Amirhossein Aminsharifi; Reza Mohamadian
Journal:  Urolithiasis       Date:  2016-03-31       Impact factor: 3.436

2.  Seoul National University Renal Stone Complexity Score for Predicting Stone-Free Rate after Percutaneous Nephrolithotomy.

Authors:  Chang Wook Jeong; Jin-Woo Jung; Woo Heon Cha; Byung Ki Lee; Sangchul Lee; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Sang Eun Lee
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

3.  Complete staghorn calculus in polycystic kidney disease: infection is still the cause.

Authors:  Zhiguo Mao; Jing Xu; Chaoyang Ye; Dongping Chen; Changlin Mei
Journal:  BMC Nephrol       Date:  2013-08-01       Impact factor: 2.388

4.  How practical is the application of percutaneous nephrolithotomy scoring systems? Prospective study comparing Guy's Stone Score, S.T.O.N.E. score and the Clinical Research Office of the Endourological Society (CROES) nomogram.

Authors:  Anurag Singla; Nikhil Khattar; Rishi Nayyar; Shibani Mehra; Hemant Goel; Rajeev Sood
Journal:  Arab J Urol       Date:  2017-01-12

Review 5.  What's new in percutaneous nephrolithotomy.

Authors:  Arvind P Ganpule; Mahesh R Desai
Journal:  Arab J Urol       Date:  2012-08-14

6.  External validation and evaluation of reliability and validity of the S-ReSC scoring system to predict stone-free status after percutaneous nephrolithotomy.

Authors:  Min Soo Choo; Chang Wook Jeong; Jae Hyun Jung; Seung Bae Lee; Hyeon Jeong; Hwancheol Son; Hyeon Hoe Kim; Seung-June Oh; Sung Yong Cho
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  Percutaneous nephrolithotomy versus open surgery for surgical treatment of patients with staghorn stones: A systematic review and meta-analysis.

Authors:  Yiwen Chen; Jianhua Feng; Haifeng Duan; Youwei Yue; Chaofeng Zhang; Tuo Deng; Guohua Zeng
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

8.  No staghorn calculi and none/mild hydronephrosis may be risk factors for severe bleeding complications after percutaneous nephrolithotomy.

Authors:  Xue Dong; Dongnv Wang; Huangqi Zhang; Shuzong You; Wenting Pan; Peipei Pang; Chaoqian Chen; Hongjie Hu; Wenbin Ji
Journal:  BMC Urol       Date:  2021-08-13       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.